J Am Acad Child Adolesc Psychiatry. 1992 Mar;31(2):226-34.

Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.

Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD.

Source

University of Rochester, New York 14627.

Abstract

Nineteen children with attention deficit disorder (ADD) participated in a double-blind trial consisting of four 2-week phases: sustained-release methylphenidate (MPH); standard MPH; a combination of standard and sustained-release MPH; and placebo. Pharmacological treatments were evaluated by means of parent and teacher ratings and open-ended comments, examiner ratings, and patients' performance and event-related potentials during Continuous Performance and Paired-Associate Learning Tests. Results revealed that the MPH conditions were superior to placebo and comparable to one another. Within the limited time frame of the research, the findings suggest comparable effectiveness for sustained-release and standard preparations of MPH.

PMID:: 1564023; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Attention Deficit Hyperactivity Disorder - MedlinePlus Health Information

Molecular Biology Databases

METHYLPHENIDATE - HSDB

Supplemental Content

Save items

Related citations in PubMed

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). [Pediatrics. 2004]
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, et al. Pediatrics. 2004 Mar; 113(3 Pt 1):e206-16.
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. [Pediatrics. 2001]
Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.
Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, et al. Pediatrics. 2001 Jun; 107(6):E105.
Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens. [J Child Adolesc Psychopharmaco...]
Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens.
Teicher MH, Polcari A, Foley M, Valente E, McGreenery CE, Chang WW, McKay G, Midha KK. J Child Adolesc Psychopharmacol. 2006 Aug; 16(4):416-31.
Review A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. [Health Technol Assess. 2006]
Review A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.
King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R. Health Technol Assess. 2006 Jul; 10(23):iii-iv, xiii-146.
Review Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations. [Pharmacotherapy. 2003]
Review Advances in the pharmacotherapy of attention-deficit-hyperactivity disorder: focus on methylphenidate formulations.
Markowitz JS, Straughn AB, Patrick KS. Pharmacotherapy. 2003 Oct; 23(10):1281-99.

See reviews... See all...

Cited by 1 PubMed Central article

Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. [Neuropsychopharmacology. 2011]
Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD.
Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M. Neuropsychopharmacology. 2011 Apr; 36(5):1060-72. Epub 2011 Jan 19.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Effects of sustained-release and standard preparations of methylphenidate on att...
Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.
J Am Acad Child Adolesc Psychiatry. 1992 Mar ;31(2):226-34.

PubMed
Characterization of ichthyocidal activity of Pfiesteria piscicida: dependence on...
Characterization of ichthyocidal activity of Pfiesteria piscicida: dependence on the dinospore cell density.
Appl Environ Microbiol. 2005 Jan ;71(1):519-29.

PubMed
Methylphenidate response in aggressive and nonaggressive ADHD children: distinct...
Methylphenidate response in aggressive and nonaggressive ADHD children: distinctions on laboratory measures of symptoms.
J Am Acad Child Adolesc Psychiatry. 1992 Mar ;31(2):219-25.

PubMed
Role of oxalic acid overexcretion in transformations of toxic metal minerals by ...
Role of oxalic acid overexcretion in transformations of toxic metal minerals by Beauveria caledonica.
Appl Environ Microbiol. 2005 Jan ;71(1):371-81.

PubMed
Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders.
Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders.
J Am Acad Child Adolesc Psychiatry. 1992 Mar ;31(2):210-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information